Telo Genomics Corp.
TDSGF
$0.0882
$0.020630.47%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 1.76% | -18.56% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.31% | -7.48% | |||
| Operating Income | -12.31% | 7.48% | |||
| Income Before Tax | -8.27% | 7.44% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -8.27% | 7.44% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -8.27% | 7.44% | |||
| EBIT | -12.31% | 7.48% | |||
| EBITDA | -12.83% | 7.01% | |||
| EPS Basic | -5.56% | 11.48% | |||
| Normalized Basic EPS | -5.88% | 10.53% | |||
| EPS Diluted | 2.74% | -19.67% | |||
| Normalized Diluted EPS | -5.88% | 10.53% | |||
| Average Basic Shares Outstanding | 2.97% | 4.12% | |||
| Average Diluted Shares Outstanding | 2.97% | 4.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
